Nuix Limited announced 1HFY23 results

Feb 20, 2023

Nuix Limited (ASX: NXL) announced 1HFY23 results as follows:

  • Annualized Contract Value (ACV) increased by 3.4% from 1HFY22 to AU$170.2 million.
  • Statutory revenue increased by 4.3% to AU$87.6 million due to better trade results in December and a favourable exchange rate.
  • EBITDA grew by 51.6% to AU$20.9 million in 1HFY23.
  • Underlying EBITDA, which does not include Topos expenditures or non-operational legal fees, increased by 8.5% on a pcp to AU$25.1 million.
  • NPAT of AU$1.3 million, a 153.8% increase from 1HFY22.
  • Customer turnover grew slightly to 4.8% throughout the year, although lower than the result in the FY22 result.
  • The company ended the 1HFY23 with AU$37.1 million in cash on hand and no debt.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com